The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Indications & Usage Section
Caffeine Withdrawal Formulated for symptoms associated with caffeine use such as cravings, headache, irritability, restlessness and fatigue.
Dosage & Administration Section
ORAL USE ONLY - SHAKE WELL. Ages 12 and up, take 6 drops orally (ages 0 to 11, give 3 drops) as needed or as directed by a healthcare professional. Sensitive persons begin with 1 drop and gradually increase to full dose.
Otc - Active Ingredient Section
Aconitum nap. 15x, Arg. nit. 15x, Arsenicum alb. 15x, Belladonna 15x, Benzoicum acidum 15x, Berber. vulg. 15x, Bryonia 15x, Cantharis 15x, Ceanothus 15x, Chelidonium majus 15x, Chionanthus virginica 15x, Cinchona 15x, Coffea cruda 15x, Conium 15x, Gelsemium 15x, Ignatia 15x, Iris versicolor 15x, Mezereum 15x, Nux vom. 15x, Passiflora 15x, Pulsatilla 15x, Rhus toxicodendron 15x, Scutellaria lateriflora 15x, Staphysag. 15x, Chamomilla 3x, Taraxacum 3x, Valeriana 3x.
Otc - Purpose Section
Formulated for symptoms associated with caffeine use such as cravings, headache, irritability, restlessness and fatigue.
Inactive Ingredient Section
Inactive Ingredients: USP Purified Water; USP Gluten-free, non-GMO, organic cane dispensing alcohol 20%.
Www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012Questions? 1.800.448.7256
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
Otc - Pregnancy Or Breast Feeding Section
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
Otc - Keep Out Of Reach Of Children Section
Keep out of reach of children.
* Please review the disclaimer below.